All Blogs

Feb 15, 2021

The Paradox of Rare: Chalking out Challenges in the Rare Disease Market


Feb 12, 2021

Limited Therapies in the Rare Disease Pipeline: Watch out for Rare Indications that Calls Out for Novel Therapies


Feb 11, 2021

Verily – Janssen collaboration; Enhancing the response in pancreatic cancer; Avrobio gene therapy eradicates toxic substrate; Gut microbiome responsible for Multiple Sclerosis


Jul 02, 2026

Progeria Syndrome: The Rarest Case of Premature Ageing


Feb 09, 2021

Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia


Feb 08, 2021

Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma


Feb 05, 2021

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market


Feb 04, 2021

Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs


Feb 03, 2021

Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization


Feb 03, 2021

Why Empathy Is More Important Today In Corporate Culture Than Ever?